Risk factors for pre-heart failure or symptomatic heart failure based on NT-proBNP
- PMID: 36151844
- PMCID: PMC9871651
- DOI: 10.1002/ehf2.14149
Risk factors for pre-heart failure or symptomatic heart failure based on NT-proBNP
Abstract
Aims: Evidence on the risk factors for incident heart failure in Asia has been limited. We sought to identify the risk factors for pre-heart failure or symptomatic heart failure, based on N-terminal pro-B-type natriuretic peptide (NT-proBNP), in the Japanese general population.
Methods: We performed a retrospective cohort study based on the Circulatory Risk in Communities Study involving 5335 Japanese individuals whose NT-proBNP levels were measured between 2010 and 2015. Of these, 2768 people aged between 30 and 69 years who undertook annual cardiovascular risk surveys at least once between 1990 and 2000 were retrospectively eligible to be participants in this study. We performed multivariable logistic regression analyses to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) of pre-heart failure or symptomatic heart failure defined as NT-proBNP >400 pg/mL or as having a diagnosis of heart failure and taking medication for heart failure for several cardiovascular risk factors (body mass index, blood pressure, diabetes mellitus, total cholesterol, triglyceride, smoking status, drinking status).
Results: We identified 85 cases of heart failure. The multivariable ORs (95% CIs) were 5.70 (2.70-12.0) for body mass index of 27-29.9 kg/m2 and 5.91 (2.19-16.0) for ≥30 kg/m2 compared with 21-22.9 kg/m2 ; 2.49(1.01-6.13) for systolic blood pressure of ≥160 mmHg vs. <130 mmHg; 2.87(1.23-6.68) for diastolic blood pressure of ≥100 mmHg vs. <80 mmHg; 5.16(2.14-12.4) for diabetes vs. non-diabetes; and 2.24 (0.92-5.49) for current smokers of ≥20 cigarettes/day vs. never smokers. The multivariable ORs (95% CIs) of the number of risk factors, defined as the sum of four risk factors (obesity, hypertension, diabetes, and current smoker) was 6.80 (3.69-12.5) for ≥2 risk factors vs. no risk factors.
Conclusions: The accumulation of these risk factors was associated with a graded higher risk of pre-heart failure or symptomatic heart failure.
Keywords: Blood pressure; Diabetes mellitus; Epidemiology; Obesity; Pre-heart failure; Smoking.
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).J Am Heart Assoc. 2018 Feb 3;7(3):e006740. doi: 10.1161/JAHA.117.006740. J Am Heart Assoc. 2018. PMID: 29431103 Free PMC article.
-
Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.Environ Health Prev Med. 2021 Apr 12;26(1):47. doi: 10.1186/s12199-021-00970-0. Environ Health Prev Med. 2021. PMID: 33845756 Free PMC article.
-
N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.Circulation. 2016 Feb 16;133(7):631-8. doi: 10.1161/CIRCULATIONAHA.115.017298. Epub 2016 Jan 8. Circulation. 2016. PMID: 26746175 Free PMC article.
-
Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.PLoS One. 2014 Nov 25;9(11):e113710. doi: 10.1371/journal.pone.0113710. eCollection 2014. PLoS One. 2014. PMID: 25423197 Free PMC article.
-
Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 May 6;21(2):1-125. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34055110 Free PMC article.
Cited by
-
The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease.Diagnostics (Basel). 2025 Jan 6;15(1):113. doi: 10.3390/diagnostics15010113. Diagnostics (Basel). 2025. PMID: 39795641 Free PMC article. Review.
-
NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.Diabetologia. 2025 Feb;68(2):342-356. doi: 10.1007/s00125-024-06299-x. Epub 2024 Nov 7. Diabetologia. 2025. PMID: 39508878 Free PMC article.
-
Life-course obesity and heart failure: a two-sample Mendelian randomization study.Intern Emerg Med. 2025 Jan;20(1):171-180. doi: 10.1007/s11739-024-03772-8. Epub 2024 Sep 24. Intern Emerg Med. 2025. PMID: 39316280
-
Association of home blood pressure with asymptomatic Stage B heart failure determined by cardiac biomarkers.Hypertens Res. 2025 Aug 15. doi: 10.1038/s41440-025-02305-w. Online ahead of print. Hypertens Res. 2025. PMID: 40817400
References
-
- Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd‐Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PWF, Woo YJ. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011; 123: 933–944. - PubMed
-
- Lloyd‐Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D. Lifetime risk for developing congestive heart failure: The Framingham heart study. Circulation. 2002; 106: 3068–3072. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials